John Akudugu
About
In The Last Decade
John Akudugu
45 papers receiving 355 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 138
- Radiology, Nuclear Medicine and Imaging 138
- Pulmonary and Respiratory Medicine 113
- Oncology 88
- Cancer Research 59
Countries citing papers authored by John Akudugu
This map shows the geographic impact of John Akudugu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Akudugu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Akudugu more than expected).
Fields of papers citing papers by John Akudugu
This network shows the impact of papers produced by John Akudugu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Akudugu. The network helps show where John Akudugu may publish in the future.
Co-authorship network of co-authors of John Akudugu
This figure shows the co-authorship network connecting the top 25 collaborators of John Akudugu. A scholar is included among the top collaborators of John Akudugu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Akudugu. John Akudugu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | PI3K and mTOR inhibitor, NVP-BEZ235, is more toxic than X-rays in prostate cancer cells | 1 |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 8 | |
| 8 | 9 | |
| 9 | 20 | |
| 10 | 14 | |
| 11 | 14 | |
| 12 | 14 | |
| 13 | 16 | |
| 14 | 18 | |
| 15 | 2 | |
| 16 | 9 | |
| 17 | 6 | |
| 18 | 5 | |
| 19 | 16 | |
| 20 | 26 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.